Vimarsana
Biggest News Aggregation in the World

Trial Snapshot News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Trial Snapshot. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Trial Snapshot Today - Breaking & Trending Today

Abramson Cancer Center doubles the percentage of Black participants in clinical trials - Vimarsana News

Abramson Cancer Center doubles the percentage of Black participants in clinical trials

Afive-year community outreach and engagement effort more than doubled the percentage of participants, improving access and treatment for a group with historically low representation in cancer research.

Source: upenn.edu
Penn doubles the percentage of Black participants in cancer clinical trials - Vimarsana News

Penn doubles the percentage of Black participants in cancer clinical trials

"An important goal of the Abramson Cancer Center is to serve and engage our community --and that includes improving access to clinical trials for all patients," said senior author Robert H. Vonderheide, MD, DPhil, director of the ACC and vice president for Cancer Programs in the University of Pennsylvania Health System. "Aligning the number of Black patients with cancer we care for with the number enrolled in our trials is how we can help bring more equitable care to the community, close gaps in disparities, and sustain trust. There's more work to be done to improve access and inclusion of m...

Penn University more than doubles the percentage of Black patients in cancer clinical trials - Vimarsana News

Penn University more than doubles the percentage of Black patients in cancer clinical trials

Penn University more than doubles the percentage of Black patients in cancer clinical trials A five-year community outreach and engagement effort by the Abramson Cancer Center at the University of Pennsylvania (ACC) to increase enrollment of Black patients into cancer clinical trials more than doubled the percentage of participants, improving access and treatment for a group with historically low representation in cancer research. The percentage of patients enrolled into a treatment clinical trial, for example, increased from 12 to 24 percent. A significant increase was also observed in non-t...